Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
52.04 USD | -0.63% | -1.27% | +31.11% |
05-08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
05-08 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.11% | 1.89B | |
+8.89% | 115B | |
+13.17% | 107B | |
-13.68% | 22.31B | |
-4.08% | 21.6B | |
-5.69% | 18.23B | |
-38.57% | 17.62B | |
+7.41% | 14.26B | |
+34.42% | 12.37B | |
-27.51% | 8.28B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics : SVB Leerink Adjusts Keros Therapeutics' Price Target to $80 from $42, Keeps Outperform Rating